Locations:
SearchAdvertisement
Robotic-Assisted Procedures Offer Breakthroughs in Lymphedema Treatment After Breast Cancer Surgery
Best practices for reducing toxicities
Ongoing clinical validation in diverse populations refine breast cancer risk substratification
Phase 3 trial found no survival differences between weekly or biweekly doxorubicin/cyclophosphamide or between weekly or biweekly paclitaxel
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Pregnancy did not appear to increase the risk of recurrence in patients or complications in their children
Polygenic risk score could help predict who will develop this aggressive breast cancer
Key research findings to watch
San Antonio Breast Cancer Symposium presentations underscore safety of assisted reproductive technology and pregnancy in women during and after breast cancer treatment
A multicenter cohort study of patients with obesity suggests a decreased risk of developing new obesity-related cancers in patients with a history of bariatric surgery
Optimized models can personalize predictions for patients with prostate, breast and other cancers
Advertisement
Advertisement